Pertuzumab biosimilar - Shanghai Henlius BiotechAlternative Names: Anti-HER2 monoclonal antibody - Shanghai Henlius Biotech; HLX 11
Latest Information Update: 18 Jun 2015
At a glance
- Originator Shanghai Henlius Biotech
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Dimerisation inhibitors; ERBB 2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Breast cancer
Most Recent Events
- 18 Jun 2015 Early research in Breast cancer in China (IV)